Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orient International Holding (OIH) is a large-scale, state-owned enterprise group based in Shanghai, China, with a significant presence in the healthcare and medical sectors through its subsidiary, Orient International Holding Shanghai Health & Medical Co., Ltd. The company operates as a comprehensive health service provider, focusing on the international trade and distribution of medical devices, pharmaceutical products, and personal protective equipment (PPE). OIH plays a pivotal role in the China International Import Expo (CIIE), representing major global healthcare brands and facilitating their entry into the Chinese market. Beyond distribution, the company is involved in health management services, medical logistics, and the development of healthcare-related infrastructure. While it is a major player in the healthcare supply chain, it is primarily a service and trading conglomerate rather than a drug discovery biotech with an internal R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orient International.